ARTICLE | Company News
Agendia, Daiichi Sankyo deal
May 5, 2014 7:00 AM UTC
Agendia will use undisclosed cancer biomarkers to assess patient samples in trials of undisclosed Daiichi products. Agendia develops and markets formalin-fixed paraffin-embedded (FFPE) genomic diagnos...